@article{917545,
      recid = {917545},
      author = {Sofia, Michael J., and Alqahtani, S. A.,},
      title = {HCV: the journey from discovery to a cure., Volume 1 /},
      pages = {1 online resource (viii, 463 pages).},
      abstract = {Hepatitis C is a liver disease caused by the hepatitis C  virus (HCV) and infects approximately 75 million  individuals worldwide. It is also one of the major causes  of liver cancer and liver transplants. The elucidation of  the HCV genome, and the development of a whole cell system  to study the virus spurred the search for novel direct  acting antiviral drugs to cure this disease. This global  effort culminated in the development of direct acting  antiviral drugs that led to cure rates approaching 100% in  all patient populations after only 8-12 weeks of therapy.  These efforts resulted in one of the greatest achievements  in public health and provides the potential for eliminating  HCV as a major disease worldwide. This volume is aimed at a  broad audience of academic and industrial scientists  interested in the discovery and development of drugs to  treat viral diseases and those interested in reading about  one of the most unique accomplishments in biomedical  research. The volume will provide a one of a kind reference  work that highlights the many efforts, from the discovery  of the HCV virus, to the invention of breakthrough  medicines and their use in the real world to cure patients.  It is the companion book to the volume "HCV: The Journey  from Discovery to a Cure - Volume II".},
      url = {http://library.usi.edu/record/917545},
      doi = {https://doi.org/10.1007/978-3-030-28},
}